Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repurposing Tc 99m Tilmanocept Imaging for Cardiac Sarcoidosis
NCT07159074Phase 2Recruiting
- Sponsor
- Duke University
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in cardiac sarcoidosis (CS), sponsored by Duke University. Started Sep 2025; status: recruiting.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
cardiac sarcoidosis (CS)
Beyond the preview
Go deeper on NCT07159074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07159074.